Key result
Re-evaluation of serum lipid values increased the proportion of hypertensive patients classified into high or very high cardiovascular risk groups to 55.2%-62.6% across different cohorts.
Why the study?
Does the evaluation of dyslipidemia improve cardiovascular risk stratification in hypertensive patients?
Population
1,817 patients with essential hypertension under medical treatment or untreated patients with systolic blood…
Design
Cross-sectional
Authors
Loading...
May support lipid re-evaluation for refined risk stratification in hypertension; hypothesis-generating and requires prospective validation.
Observational (n=1,817)
Yes
Does the evaluation of dyslipidemia improve cardiovascular risk stratification in hypertensive patients?
Evaluating serum lipid levels in hypertensive patients significantly increases the proportion identified as high or very high cardiovascular risk, allowing for more appropriate targeted treatment.
Giray Kabakçı (2008) conducted an observational in Hypertension and dyslipidemia (n=1,817). Re-evaluation of lipid values was evaluated on Percentage of patients in high plus very high added cardiovascular risk groups. Re-evaluation of serum lipid values increased the proportion of hypertensive patients classified into high or very high cardiovascular risk groups to 55.2%-62.6% across different cohorts.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: